Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: A case report

International Journal of Immunopathology and Pharmacology

Volumn 25, Issue 1, 2012, Pages 269-273

  Firinu, D ^a   Barca, M P ^a   Serusi, L ^a   Lorrai, M M ^a   Peralta, M M ^a   Manconi, P E ^a   Del Giacco, S R ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

bradykinin; C1 inhibitor; complement; HAE; hereditary angioedema; icatibant

Indexed keywords

COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C4; DANAZOL; DOXAZOSIN MESYLATE; ICATIBANT; TRANEXAMIC ACID;

ACUTE ABDOMEN; AGED; ANGIONEUROTIC EDEMA; ARTICLE; CASE REPORT; COLIC; DISEASE ACTIVITY; DRUG EFFECT; DRUG EFFICACY; DRUG SUBSTITUTION; DYSPNEA; EUROPE; FEMALE; FOLLOW UP; HUMAN; INJECTION SITE REACTION; LARYNX EDEMA; LIMB SWELLING; MUCOSA INFLAMMATION; NAUSEA; PRIORITY JOURNAL; SIDE EFFECT; SKIN SWELLING; TREATMENT OUTCOME; TREATMENT RESPONSE; ULTRASOUND; UPPER RESPIRATORY TRACT OBSTRUCTION; VIRILIZATION; VOMITING; WEIGHT GAIN;

EID: 84861468099     PISSN: 03946320     EISSN: 20587384     Source Type: Journal    
DOI: 10.1177/039463201202500130     Document Type: Article

References (18)

1. Donaldson VH, Evans RR,. A biochemical abnormality in hereditary angioneurotic edema: Absence of serum inhibitor of C'l-esterase. Am J Med 1963; 35: 37-44.
2. Morgan PB,. Hereditary angioedema-therapies old and new. N Engl J Med 2010; 363: 581-3.
3. Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A,. Plasma bradykinin in angio-oedema. Lancet 1998; 351: 1497-503.
4. Cugno M, Nussberger J, Cicardi M, Agostoni A,. Bradykinin and the pathophysiology of angiooedema. Int Immunopharmacol 2003; 3: 311-7.
5. Cicardi M, Zanichelli A,. Angioedema due to C1 inhibitor deficiency in 2010. Intern Emerg Med 2010; 5: 481-6.
6. Bork K, Siedlecki K, Bosch S, Schopf RE, Kreuz W,. Asphyxiation by laryngeal edema in patients with hereditary angioedema. Mayo Clin Proc 2000; 75: 349-54.
7. Bowen T, Cicardi M, Farkas H, et al. 2010 International consensus algorithm for diagnosis, therapy and management of hereditary angioedema. Allergy Asthma Clin Immunol 2010; 6: 24.
8. Zuraw BL,. HAE therapies: Past, present and future. Allergy Asthma Clin Immunol 2010; 6: 23.
9. Zuraw BL, Busse PJ, White M, et al. Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 2010; 363: 513-22.
10. Cicardi M, Banerji A, Bracho F, et al. Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 2010; 363: 532-41.
11. Cicardi M, Levy RJ, McNeil DL, et al. Ecallantide for the treatment of acute attacks of hereditary angioedema. N Engl J Med 2010; 363: 523-31.
12. European Medicines Agency. Summary of product characteristics. [Cited 2011 ] Available from: http://www.ema.europa.eu/docs/en-GB/document-library/EPARProduct-Information/human/000899/WC500022966.pdf
13. Varga L, Szeplaki G, Visy B, et al. C1-inhibitor (C1-INH) autoantibodies in hereditary angioedema. Strong correlation with the severity of disease in C1-INH concentrate naive patients. Mol Immunol 2007; 44: 1454-60
14. Bork K, Hardt J,. Hereditary angioedema: Increased number of attacks after frequent treatments with C1 inhibitor concentrate. Am J Med 2009; 122: 780-3.
15. Bouillet L, Boccon-Gibod I, Dumestre-Perard C, Cesbron JY, Massot C,. Efficacy of icatibant treatment in patients with hereditary angio-oedema type I resistant to treatment with C1 inhibitor concentrate. Br J Dermatol 2011; 164: 1406-7
16. Varga L, Fust G, Farkas H,. Are these patients indeed resistant to treatment with C1 inhibitor concentrate? Br J Dermatol 2012; 166 (1): 225-6.
17. Farkas H, Harmat G, Kaposi PN, et al. Ultrasonography in the diagnosis and monitoring of ascites in acute abdominal attacks of hereditary angioneurotic oedema. Eur J Gastroenterol Hepatol 2001; 13: 1225-30.
18. Pedrosa M, Caballero T, Gómez-Traseira C, Olveira L, Lopez-Serrano C,. Usefulness of abdominal ultrasonography in the follow-up of patients with hereditary C1-inhibitor deficiency. Am Allergy Asthma Immunol 2009; 102: 483-6.